SCHEMBL3474345

SCHEMBL3474345

CC(C)(C)Cn1nnc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
AMY1A P0DUB6 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
ATM Q13315 1/20 0.44
CYP1A2 P05177 1/20 0.43
PTK2 Q05397 2/20 0.41
MAPT P10636 3/20 0.40
NSD2 O96028 1/20 0.40
PKM P14618 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP2D6 P10635 1/20 0.39
GLS O94925 1/20 0.39
HPGD P15428 1/20 0.39
HCAR3 P49019 1/20 0.39
TXNRD1 Q16881 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20986085 0.89 ALDH1A1 (0.46) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911535 0.84 HCAR3 (0.55) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911532 0.82 HCAR3 (0.57) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911537 0.81 ALDH1A1 (0.47) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911547 0.81 ALDH1A1 (0.44) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911531 0.80 HCAR3 (0.59) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911558 0.78 HCAR3 (0.55) ALDH1A1GAACYP1A2MAPTNSD2
SCHEMBL2001605 0.78 HCAR3 (0.43) ATMMAPTHCAR3
SCHEMBL19911534 0.78 ALDH1A1 (0.44) ALDH1A1GAAMGAMAMY1ASI
SCHEMBL19911543 0.78 ALDH1A1 (0.44) ALDH1A1GAAMGAMAMY1ASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2705024-B1 Alkyne benzotriazole derivatives MERCK SHARP & DOHME (US) 2015-12-16 EP disclosed
US-9139576-B2 Aminomethyl biaryl benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-09-22 US disclosed
US-9139576-B2 Aminomethyl biaryl benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-09-22 US disclosed
US-9139576-B2 Aminomethyl biaryl benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-09-22 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed
WO-2010141360-A1 BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2010-12-09 WO disclosed
WO-2010141360-A1 BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2010-12-09 WO disclosed
WO-2010114726-A1 AMINOBENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2010-10-07 WO disclosed
WO-2010114726-A1 AMINOBENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 ALDH1A1 3327/4885GAA 2583/4885MGAM 3469/4885
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 ALDH1A1 3327/4885GAA 2583/4885MGAM 3469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.